SE8702697L - PREPARATION OF MEDICINAL PRODUCTS FOR TREATMENT OF ISCHEMIC Vascular Diseases - Google Patents
PREPARATION OF MEDICINAL PRODUCTS FOR TREATMENT OF ISCHEMIC Vascular DiseasesInfo
- Publication number
- SE8702697L SE8702697L SE8702697A SE8702697A SE8702697L SE 8702697 L SE8702697 L SE 8702697L SE 8702697 A SE8702697 A SE 8702697A SE 8702697 A SE8702697 A SE 8702697A SE 8702697 L SE8702697 L SE 8702697L
- Authority
- SE
- Sweden
- Prior art keywords
- alkyl
- treatment
- vascular diseases
- preparation
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Pharmaceutical compositions for treatment of ischaemic vascular diseases comprise a haemorheologically active calcium antagonist of formula I, <IMAGE> and a pharmaceutically acceptable carrier, wherein R1 is H, C1-6 alkyl, alkenyl or alkinyl, cycloalkyl, phenylalkyl or phenylalkenyl, wherein the phenyl ring may be substituted by halogen, alkyl, hydroxy or alkoxy; R3 and R4 are as for R1, or may be alkoxy, alkenoxy or alkinoxy; R2 and R5 are each hydrogen or alkyl, R6 is H, halogen, alkyl, alkoxy,alkylsulphonyl or alkylthio, and X is oxygen or sulphur.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868616047A GB8616047D0 (en) | 1986-07-01 | 1986-07-01 | A 1 4-dihydropyridine derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8702697D0 SE8702697D0 (en) | 1987-06-30 |
| SE8702697L true SE8702697L (en) | 1988-01-02 |
Family
ID=10600369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8702697A SE8702697L (en) | 1986-07-01 | 1987-06-30 | PREPARATION OF MEDICINAL PRODUCTS FOR TREATMENT OF ISCHEMIC Vascular Diseases |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS6322519A (en) |
| KR (1) | KR880001643A (en) |
| AU (1) | AU7491487A (en) |
| DE (1) | DE3720509A1 (en) |
| DK (1) | DK333587A (en) |
| FR (1) | FR2601012A1 (en) |
| GB (2) | GB8616047D0 (en) |
| IT (1) | IT1216830B (en) |
| SE (1) | SE8702697L (en) |
| ZA (1) | ZA874768B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4011695A1 (en) * | 1990-04-11 | 1991-10-17 | Bayer Ag | USE OF N-ALKYLATED 1,4-DIHYDROPYRIDE INDICARBOXIC ACID ESTERS AS DRUGS, NEW COMPOUNDS AND METHOD FOR THEIR PREPARATION |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI64938C (en) * | 1977-06-20 | 1984-02-10 | Sandoz Ag | PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC THERAPEUTIC BENSOX A- AND OX BENZOTIADIAZOLYL-1,4-DIHYDROPYRID DERIVATIVES |
-
1986
- 1986-07-01 GB GB868616047A patent/GB8616047D0/en active Pending
-
1987
- 1987-06-20 DE DE19873720509 patent/DE3720509A1/en not_active Withdrawn
- 1987-06-25 IT IT8748101A patent/IT1216830B/en active
- 1987-06-26 FR FR8709111A patent/FR2601012A1/en active Pending
- 1987-06-29 DK DK333587A patent/DK333587A/en not_active Application Discontinuation
- 1987-06-29 AU AU74914/87A patent/AU7491487A/en not_active Abandoned
- 1987-06-29 GB GB08715219A patent/GB2192132A/en not_active Withdrawn
- 1987-06-30 SE SE8702697A patent/SE8702697L/en not_active Application Discontinuation
- 1987-06-30 JP JP62165135A patent/JPS6322519A/en active Pending
- 1987-07-01 KR KR1019870006952A patent/KR880001643A/en not_active Application Discontinuation
- 1987-07-01 ZA ZA874768A patent/ZA874768B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB2192132A (en) | 1988-01-06 |
| DE3720509A1 (en) | 1988-01-28 |
| IT8748101A0 (en) | 1987-06-25 |
| SE8702697D0 (en) | 1987-06-30 |
| IT1216830B (en) | 1990-03-14 |
| ZA874768B (en) | 1989-02-22 |
| DK333587A (en) | 1988-01-02 |
| GB8616047D0 (en) | 1986-08-06 |
| DK333587D0 (en) | 1987-06-29 |
| AU7491487A (en) | 1988-01-07 |
| JPS6322519A (en) | 1988-01-30 |
| GB8715219D0 (en) | 1987-08-05 |
| FR2601012A1 (en) | 1988-01-08 |
| KR880001643A (en) | 1988-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL68494A (en) | Dihydropyridine derivatives,their production and pharmaceutical compositions comprising them | |
| ATE79376T1 (en) | DITHIOACETAL COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| DE3881472D1 (en) | HETEROCYCLIC COMPOUNDS WITH THERAPEUTIC EFFECT. | |
| FI872864A (en) | Process for the preparation of pharmaceutically active benzimidazole compounds | |
| NO160076C (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZOCSAZOL AND BENZOTIANOLAMIN DERIVATIVES. | |
| FI945538A0 (en) | 7- (2-Aminoethyl) -bensotiazoloner | |
| ATE186301T1 (en) | 4H-PYRIDO-(1,2-A)PYRIMIDINE-4-ONE SUBSTITUTED AT POSITIONS 2 AND 9 | |
| DE3873578D1 (en) | USE OF TETRAHYDROBENZ (C, D) INDOL-6-CARBOXAMIDES FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF ANXIETIES. | |
| NO881835L (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BICYCLIC RELATIONS. | |
| HU9201033D0 (en) | Tiazolidinone- and oxazolidinone derivatives, process for their production, and for the production of medical preparations containing them as active agents | |
| DE3274860D1 (en) | Triazoloquinazolones and their salts, process and intermediates for preparing them, their use as medicines and compositions containing them | |
| DK148288A (en) | N-PHENETHYLAMINOALKYL-BENZAMIDE COMPOUNDS, THEIR USE FOR THE PREPARATION OF ANTIARRHYTHMIA MEDICINALS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE COMPOUNDS | |
| SE8702697L (en) | PREPARATION OF MEDICINAL PRODUCTS FOR TREATMENT OF ISCHEMIC Vascular Diseases | |
| ATE38982T1 (en) | GUANIDINMETHYLCYCLOHEXANECARBONIC ACID DERIVATIVES, PROCESSES FOR MANUFACTURE AND PHARMACEUTICAL AGENTS. | |
| NO165106C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-AMINOALKYL-BETA CARBOLINE DERIVATIVES. | |
| DE69327077T2 (en) | Carbamoylpyrrolidone derivatives for the treatment of depression and cerebrovascular disorders | |
| DE3782235D1 (en) | USE OF 2-OXO-IMIDAZOLIDINE DERIVATIVES FOR PROPHYLAXIS AND FOR THE TREATMENT OF HEART INSUFFICIENCY. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8702697-7 Effective date: 19890720 |